Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on January 3, 2007. The report discloses the consolidated financial results for the second quarter of fiscal year 2007, which ended on November 26, 2006.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not describe specific material changes versus the prior comparable period. It serves solely as a notification that the results for the quarter ended November 26, 2006, have been announced via a press release.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. The document strictly references the attached press release for the full disclosure of operational results.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net income, EPS) in the attached Exhibit 99.1 Press Release.
- Confirm the discrepancy between the request metadata ("LIFECORE BIOMEDICAL, INC.") and the filing registrant ("Landec Corporation").
- Review the press release for any year-over-year comparisons or guidance updates not detailed in this 8-K summary.